Bausch Health
BHC
#4210
Rank
S$3.32 B
Marketcap
S$8.98
Share price
-6.10%
Change (1 day)
-20.90%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): S$1.25

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is S$1.26. In 2024 the company made an earnings per share (EPS) of S-$0.16 an increase over its 2023 EPS that were of S-$2.10.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$1.25-905.89%
2024S-$0.16-92.59%
2023S-$2.10160.89%
2022S-$0.80-76.64%
2021S-$3.4468.45%
2020S-$2.04-68.91%
2019S-$6.57-57.11%
2018S-$15.33-272.22%
2017S$8.90-199.29%
2016S-$8.96798.7%
2015S-$1.00-128.31%
2014S$3.52-204.62%
2013S-$3.37602.7%
2012S-$0.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
S-$1.23-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
S-$0.31-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA